Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Lymphocytic Neoplasm — Research · CancerIndex

Cancers
Neoplasm
Neoplasm by Morphology
Hematopoietic and Lymphoid Cell Neoplasm
Lymphocytic Neoplasm

Cancer Family

Lymphocytic Neoplasm

CI-CAN-00000223Explore in graph →

HematologicNon-malignant3,036 active trials72 approved drugs345 evidence items

NCIt: C7065

Overview
Statistics
Survival
Genomics38
Variants & evidence345
Drugs51
Trials12949
Research
Rankings
Sources & provenance

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Trials tab
Methodology: publication counts

Literature

Linked publications (380)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedProvenance

Source: PubMed (NLM)
Dataset: PubMed E-utilities
Retrieved: Sep 8, 2026
Layer: normalized (units and labels harmonized; values unchanged)

PublishedShowing 251–275 of 380 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Targeting the BRAF V600E mutation in multiple myeloma.
· Cancer Discov · 2013 · PMID 23612012 · validated civic_curation pubmed
Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma.
· Blood · 2012 · PMID 22210878 · validated civic_curation pubmed
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation.
· J Exp Med · 2011 · PMID 21670202 · validated civic_curation pubmed
IKZF1 status as a prognostic feature in BCR-ABL1-positive childhood ALL.
· Blood · 2014 · PMID 24366361 · validated civic_curation pubmed
IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report.
· J Clin Oncol · 2009 · PMID 19770381 · validated civic_curation pubmed
IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL.
· Leukemia · 2010 · PMID 20445578 · validated civic_curation pubmed
IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma.
· Blood · 2015 · PMID 26268241 · validated civic_curation pubmed

Showing 251–275 of 380 publications

← Previous
1
…
10
11
12
…
16
Next →

p53 gene mutation in B-cell chronic lymphocytic leukemia is associated with drug resistance and is independent of MDR1/MDR3 gene expression.

· Blood · 1993 · PMID 8241511 · validated civic_curation pubmed

Mutational status of the TP53 gene as a predictor of response and survival in patients with chronic lymphocytic leukemia: results from the LRF CLL4 trial.

· J Clin Oncol · 2011 · PMID 21483000 · validated civic_curation pubmed

Deficiency of the ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukemia.

· Cancer Res · 1998 · PMID 9788599 · validated civic_curation pubmed

Complex karyotypes and KRAS and POT1 mutations impact outcome in CLL after chlorambucil-based chemotherapy or chemoimmunotherapy.

· Blood · 2016 · PMID 27226433 · validated civic_curation pubmed

ATM gene alterations in chronic lymphocytic leukemia patients induce a distinct gene expression profile and predict disease progression.

· Haematologica · 2012 · PMID 21993670 · validated civic_curation pubmed

NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma.

· Nat Med · 2015 · PMID 26193344 · validated civic_curation pubmed

BCL2 mutations are associated with increased risk of transformation and shortened survival in follicular lymphoma.

· Blood · 2015 · PMID 25452615 · validated civic_curation pubmed

Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases.

· Proc Natl Acad Sci U S A · 2018 · PMID 30487223 · validated civic_curation pubmed

Prognostic impact of kinase-activating fusions and IKZF1 deletions in pediatric high-risk B-lineage acute lymphoblastic leukemia.

· Blood Adv · 2018 · PMID 29507076 · validated civic_curation pubmed

Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphoma.

· Blood Adv · 2020 · PMID 32589730 · validated civic_curation pubmed

Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact.

· Blood · 2019 · PMID 30602617 · validated civic_curation pubmed

Chromosomal abnormalities identify high-risk and low-risk patients with acute lymphoblastic leukemia.

· Blood · 1986 · PMID 3455828 · validated civic_curation pubmed

TCF3 gene rearrangements in pediatric B-cell acute lymphoblastic leukemia-A single center experience.

· Int J Lab Hematol · 2023 · PMID 37058324 · validated civic_curation pubmed

B-ALL With t(5;14)(q31;q32); IGH-IL3 Rearrangement and Eosinophilia: A Comprehensive Analysis of a Peculiar IGH-Rearranged B-ALL.

· Front Oncol · 2019 · PMID 31921638 · validated civic_curation pubmed

Experience with provisional WHO-entities large B-cell lymphoma with IRF4-rearrangement and Burkitt-like lymphoma with 11q aberration in paediatric patients of the NHL-BFM group.

· Br J Haematol · 2020 · PMID 32239695 · validated civic_curation pubmed

Alemtuzumab is an effective therapy for chronic lymphocytic leukemia with p53 mutations and deletions.

· Blood · 2004 · PMID 14726385 · validated civic_curation pubmed

Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma.

· Blood · 2012 · PMID 22383795 · validated civic_curation pubmed

Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia.

· N Engl J Med · 2015 · PMID 26352686 · validated civic_curation pubmed